Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Moolenaar LR, Ali M, Aufenacker TJ, Beets GL, Bosker RJI, Buffart TE, Burger JW, Dekker E, Denost Q, Doornebosch PG, Duijvendijk PV, Fabry HFJ, Geijsen ED, Gerhards MF, van Grevenstein WMU, Grotenhuis BA, Hoff C, Leijtens JWA, Peeters KCMJ, Pronk A, van der Schelling GP, Sietses C, Smits AB, Toorenvliet BR, van de Ven AWH, Verdaasdonk EGG, Vuylsteke RJCLM, van Westreenen HL, de Wilt JHW, Zimmerman DDE, Lange MM, van Grieken NCT, Bastiaansen BAJ, Hompes R, Marijnen CA, Dijkgraaf MGW, Moons LMG, Tanis PJ, Cunningham C, Tuynman JB, TESAR Study Group

Open source

DOI
10.1016/s2468-1253(26)00109-3
Published
2026 Jul
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00109-3,
  title = {Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.},
  author = {Moolenaar LR and Ali M and Aufenacker TJ and Beets GL and Bosker RJI and Buffart TE and Burger JW and Dekker E and Denost Q and Doornebosch PG and Duijvendijk PV and Fabry HFJ and Geijsen ED and Gerhards MF and van Grevenstein WMU and Grotenhuis BA and Hoff C and Leijtens JWA and Peeters KCMJ and Pronk A and van der Schelling GP and Sietses C and Smits AB and Toorenvliet BR and van de Ven AWH and Verdaasdonk EGG and Vuylsteke RJCLM and van Westreenen HL and de Wilt JHW and Zimmerman DDE and Lange MM and van Grieken NCT and Bastiaansen BAJ and Hompes R and Marijnen CA and Dijkgraaf MGW and Moons LMG and Tanis PJ and Cunningham C and Tuynman JB and TESAR Study Group},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00109-3},
  url = {https://doi.org/10.1016/s2468-1253(26)00109-3}
}

RIS

TY  - JOUR
TI  - Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
AU  - Moolenaar LR
AU  - Ali M
AU  - Aufenacker TJ
AU  - Beets GL
AU  - Bosker RJI
AU  - Buffart TE
AU  - Burger JW
AU  - Dekker E
AU  - Denost Q
AU  - Doornebosch PG
AU  - Duijvendijk PV
AU  - Fabry HFJ
AU  - Geijsen ED
AU  - Gerhards MF
AU  - van Grevenstein WMU
AU  - Grotenhuis BA
AU  - Hoff C
AU  - Leijtens JWA
AU  - Peeters KCMJ
AU  - Pronk A
AU  - van der Schelling GP
AU  - Sietses C
AU  - Smits AB
AU  - Toorenvliet BR
AU  - van de Ven AWH
AU  - Verdaasdonk EGG
AU  - Vuylsteke RJCLM
AU  - van Westreenen HL
AU  - de Wilt JHW
AU  - Zimmerman DDE
AU  - Lange MM
AU  - van Grieken NCT
AU  - Bastiaansen BAJ
AU  - Hompes R
AU  - Marijnen CA
AU  - Dijkgraaf MGW
AU  - Moons LMG
AU  - Tanis PJ
AU  - Cunningham C
AU  - Tuynman JB
AU  - TESAR Study Group
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00109-3
UR  - https://doi.org/10.1016/s2468-1253(26)00109-3
ER  -

APA

LR, M., M, A., TJ, A., GL, B., RJI, B., TE, B., JW, B., E, D., Q, D., PG, D., PV, D., HFJ, F., ED, G., MF, G., WMU, V. G., BA, G., C, H., JWA, L., KCMJ, P., A, P., GP, V. D. S., C, S., AB, S., BR, T., AWH, V. D. V., EGG, V., RJCLM, V., HL, V. W., JHW, D. W., DDE, Z., MM, L., NCT, V. G., BAJ, B., R, H., CA, M., MGW, D., LMG, M., PJ, T., C, C., JB, T., & Group, T. S. (2026). Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00109-3

Source records